Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer
Crossref DOI link: https://doi.org/10.1007/s12020-016-1080-9
Published Online: 2016-10-01
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Latteyer, Soeren
Tiedje, Vera
König, Katharina
Ting, Saskia
Heukamp, Lukas C.
Meder, Lydia
Schmid, Kurt Werner
Führer, Dagmar
Moeller, Lars Christian
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (FU356 3-3)
License valid from 2016-10-01